乾式化学分析装置の世界市場（2025年～2033年）

世界の乾式化学分析装置の市場規模は、2024年に177億6,000万米ドルに達し、2033年には286億6,000万米ドルに達すると予測され、予測期間2025年～2033年にはCAGR4.2%で成長する見通しです。

乾式化学分析装置は、液体試薬を使用せずにサンプルを分析できる機械ですが、分析前にサンプルと混合する事前計量された試薬パックを通過します。しかし、これは臨床検査室では一般的で、血糖値、コレステロール、肝機能など患者の重要なパラメーターを検査します。乾式化学分析装置は非常に正確ですが、使用者のミスや試料の質の悪さによって誤った結果を出すこともあります。そのため、検査スタッフの適切なトレーニングと定期的な校正が必要となります。

市場力学：

促進要因と抑制要因

ポイントオブケア（POC）診断への需要の高まり

世界の乾式化学分析装置市場は、ポイントオブケア（POC）診断に対する需要の高まりによって成長しています。POC診断は、患者の治療現場で迅速かつ正確な検査を可能にし、集中検査室の必要性と所要時間を削減します。これは特に救急医療、遠隔地ヘルスケア、外来診療において有益です。乾式化学分析装置はポータブルで使いやすく、効率的であるため、POC用途に最適です。糖尿病や心血管疾患のような慢性疾患の増加がPOC診断の普及に拍車をかけており、個別化医療への世界のシフトが最新のPOC診断ソリューションにおける乾式化学の役割を確固たるものにしています。

例えば、富士フイルムのDri-Chemistry Analyzersは、使いやすさ、正確さ、利便性を提供し、診断検査をリードしています。これらの分析装置はキャリブレーションが不要で、シンプルなプラグアンドプレイのセットアップで動作し、どのようなヘルスケア環境でも使用できるほどコンパクトです。また、最小限のトレーニングしか必要としないため、遠隔地や資源の限られた環境での使用に最適です。

限られた感度と特異度

乾式化学分析装置は、その感度と特異度の低さから、世界市場で課題に直面しています。乾式化学は利便性が高く、納期も短くなっていますが、湿式化学システムと比較すると、低濃度分析物の検出や複雑な診断検査への対応において堅牢性に欠けます。このため、高精度を必要とする特殊な臨床検査室や高度な診断手順への応用が制限されます。これは診断の不正確さにつながり、臨床医の信頼性を低下させ、高精度が求められる医療現場での採用の妨げとなります。市場は今、このような要求に応えるため、乾式化学システムの分析能力を革新し、向上させる必要に迫られています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • ポイントオブケア（POC）診断の需要増加
  • 抑制要因
    • 感度と特異性の限界
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 製品タイプ別

• 機器
• 消耗品

第7章 技術別

• 反射光度測定
• 比色分析
• 濁度測定
• 蛍光

第8章 用途別

• 血液化学分析
• 尿検査
• 代謝パネル検査
• 肝臓および腎臓機能検査
• 電解質分析

第9章 エンドユーザー別

• 診断検査室
• 病院
• 外来診療センター
• 学術研究機関
• ポイントオブケア検査施設

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• FUJIFILM India Private Limited
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 実績および予測の製品販売
    • 製品販売量
  • 財務概要
    • 企業収益
    • 地域別収益シェア
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• F. Hoffmann-La Roche Ltd.
• Siemens Healthineers
• Abbott Laboratories
• Beckman Coulter, Inc.（A subsidiary of Danaher Corporation）
• Ortho Clinical Diagnostics
• Sysmex Corporation
• Thermo Fisher Scientific, Inc
• Randox Laboratories Ltd
• Wondfo
• HORIBA, Ltd
  • パイプライン製品の説明
  • 製品の主要業績評価指標（KPI）
  • 主な活動
  • 市場参入のタイムライン
  • 製品普及率
  • 売上推定と予測
• Arkray, Inc.
• URIT Medical Electronic Co., Ltd.
• DIRUI Industrial Co., Ltd.
• Medica Corporation
• EKF Diagnostics

第12章 付録

The global dry chemistry analyzer market reached US$ 17.76 billion in 2024 and is expected to reach US$ 28.66 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.

A dry chemistry analyser is a machine that can analyse samples without using liquid reagents, but goes through pre-measured reagent packets that mix with the sample before analysis. This is, however, common in a clinical laboratory; where it tests important parameters in a patient such as blood glucose, cholesterol, and liver function. Dry chemistry analyzers would be very accurate; however, a few occasions do produce false results due to mistakes by users or due to a poor sample quality. This calls for proper training of laboratory staff and regular calibration.

Market Dynamics: Drivers & Restraints

Increasing Demand for Point-of-care (POC) Diagnostics

The global dry chemistry analyzer market is growing due to the growing demand for point-of-care (POC) diagnostics. POC diagnostics enable quick, accurate testing near patient care sites, reducing the need for centralized labs and turnaround times. This is particularly beneficial in emergency care, remote healthcare settings, and outpatient clinics. Dry chemistry analyzers are portable, easy to use, and efficient, making them ideal for POC applications. The rise in chronic diseases like diabetes and cardiovascular conditions has fueled the adoption of POC diagnostics, and the global shift towards personalized healthcare has solidified their role in modern POC diagnostic solutions.

For instance, Fujifilm Dri-Chemistry Analyzers are leading the charge in diagnostic testing, offering ease of use, accuracy, and convenience. These analyzers require no calibration, operate on a simple plug-and-play setup, and are compact enough for any healthcare setting. They also require minimal training and are ideal for remote and resource-limited environments.

Limited Sensitivity and Specificity

Dry chemistry analyzers face challenges in the global market due to their limited sensitivity and specificity. Despite their convenience and quick turnaround time, they are less robust in detecting low-concentration analytes and handling complex diagnostic tests compared to wet chemistry systems. This restricts their application in specialized clinical laboratories and advanced diagnostic procedures that require high precision. This can lead to diagnostic inaccuracies, reducing clinician confidence and hindering adoption in high-stakes medical environments. The market is now pressured to innovate and improve dry chemistry systems' analytical capabilities to meet these demands.

For more details on this report - Request for Sample

Segment Analysis

The global dry chemistry analyzer market is segmented based on product type, technology, application, end user and region.

Product Type:

Instruments segment is expected to dominate the Dry Chemistry Analyzer market share

The instruments segment holds a major portion of the dry chemistry analyzer market share and is expected to continue to hold a significant portion of the dry chemistry analyzer market share during the forecast period.

Instruments play a crucial role in the global dry chemistry analyzer market, as they are diagnostic tools for rapid and accurate testing of biological samples. They are used to diagnose and monitor medical conditions like diabetes, kidney disorders, and liver diseases. Modern instruments' compactness and user-friendliness have increased their adoption in point-of-care settings, outpatient clinics, and rural healthcare facilities.

The DRI-CHEM from FUJIFILM is a dry chemistry analyzer capable of performing multiple clinical chemistry test parameters. It features an auto-pipetting system, requires no calibration, and requires no water, making preparation and maintenance easy. The DRI-CHEM NX500 offers "Real Time and Borderless" Clinical Chemistry.

End User:-

Diagnostic Laboratories segment is the fastest-growing segment in Dry Chemistry Analyzer market share

The diagnostic laboratories segment is the fastest-growing segment in the dry chemistry analyzer market share and is expected to hold the market share over the forecast period.

Diagnostic laboratories are key users of dry chemistry analyzers for various diagnostic applications, including metabolic disorders, liver function, kidney function, and cardiovascular diseases. These analyzers offer accurate, quick, and reliable results, making them ideal for high-throughput environments. They process multiple samples simultaneously, reducing reagent usage and contamination risk. The ease of use, automation, and minimal maintenance requirements of dry chemistry analyzers support laboratories in meeting increasing demand for diagnostic testing.

For instance, in July 2024, Beckman Coulter Diagnostics has introduced the DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer. This innovative solution addresses the needs of healthcare systems worldwide, offering solutions for satellite or independent laboratories and core laboratories. Utilizing Beckman Coulter's scalable clinical chemistry and immunoassay portfolio, the DxC 500i Analyzer enables commutable patient results, providing strategic benefits in patient care and inventory management for hospitals and healthcare networks.

Geographical Analysis

North America is expected to hold a significant position in the Dry Chemistry Analyzer market share

North America holds a substantial position in the dry chemistry analyzer market and is expected to hold most of the market share due to its product launches, significant advancements, high adoption of diagnostic technologies. Moreover, the rising prevalence of chronic diseases like diabetes, cardiovascular disorders, and kidney ailments has increased demand for reliable diagnostic solutions. The region's focus on point-of-care testing, substantial healthcare funding, and favorable reimbursement policies have accelerated the adoption of dry chemistry analyzers. Leading market players and ongoing R&D activities further drive innovation.

For instance, in April 2024, he URIT UC-1800 Urine Analyzer has passed the U.S. FDA approval, marking its success as part of the URIT US-2000 series artificial intelligence. This dry chemical analysis module has a single measuring speed of up to 480T/H, making it suitable for high-end markets. It also offers charts and traceable results, with a maximum of 500 test strips in a single run, constant temperature reaction, and easy operation. The UC-1800 provides stable and reliable test results.

Asia Pacific is growing at the fastest pace in the Dry Chemistry Analyzer market

Asia Pacific holds the fastest pace in the dry chemistry analyzer market and is expected to hold most of the market share due to rise in chronic diseases and the need for affordable diagnostic solutions. The aging population and improved healthcare infrastructure in countries like China, India, and Japan are driving the demand for cost-effective diagnostic tools. Government initiatives and the adoption of point-of-care testing in rural areas are also contributing to the market's robust growth.

For instance, chronic diseases are prevalent among older adults in China, with advanced socioeconomic status having a dual-edged impact on their prevalence. The Chinese population has a high prevalence of chronic diseases, with a national prevalence of 81.1%, affecting 179.9 Billion older adults. The prevalence increases with aging and peaking at 80-84 years old. Women, rural residents, and ethnic minorities have a higher prevalence than men, urban residents, and Han ethnicity.

Hence, due to the high prevalence of chronic diseases among older adults, which necessitates rapid, cost-effective, and user-friendly diagnostic tools, especially for underserved populations like rural residents and ethnic minorities which indeed helps the overall growth of the market.

Competitive Landscape

The major global players in the dry chemistry analyzer market include FUJIFILM India Private Limited, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Abbott Laboratories, Beckman Coulter, Inc. (A subsidiary of Danaher Corporation), Ortho Clinical Diagnostics, Sysmex Corporation, Thermo Fisher Scientific, Inc, Randox Laboratories Ltd, Wondfo and among others.

Key Developments

• In Febraury 2024, Beckman Coulter Diagnostics unveiled its new DxC 500 AU Chemistry Analyzer at Medlab Middle East in Dubai on February 5-8, 2024. This automated clinical chemistry analyzer is part of a series of solutions designed to enhance the capabilities of satellite and independent hospital laboratories, complementing central hub laboratories.
• In July 2023, Siemens Healthineers Atellica has received FDA clearance for its 1 in vitro diagnostic for immunoassay and clinical chemistry testing. The analyzer offers competitive advantages for labs with low to medium testing volumes, including improved turnaround time predictability, advanced reporting functionality, and safety and security measures.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global dry chemistry analyzer market report delivers a detailed analysis with 75+ key tables, more than 65 visually impactful figures, and 227 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Demand for Point-of-care (POC) Diagnostics
  • 4.1.2. Restraints
    • 4.1.2.1. Limited Sensitivity and Specificity
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Instruments*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Consumables

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Reflectance Photometry*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Colorimetry
• 7.4. Turbidimetry
• 7.5. Fluorescence

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Blood Chemistry Analysis*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Urinalysis
• 8.4. Metabolic Panel Testing
• 8.5. Liver and Renal Function Testing
• 8.6. Electrolyte Analysis

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Diagnostic Laboratories*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Hospitals
• 9.4. Ambulatory Care Centers
• 9.5. Academic and Research Institutes
• 9.6. Point-of-Care Testing Facilities

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

• 12.1. FUJIFILM India Private Limited*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. F. Hoffmann-La Roche Ltd.
• 12.3. Siemens Healthineers
• 12.4. Abbott Laboratories
• 12.5. Beckman Coulter, Inc. (A subsidiary of Danaher Corporation)
• 12.6. Ortho Clinical Diagnostics
• 12.7. Sysmex Corporation
• 12.8. Thermo Fisher Scientific, Inc
• 12.9. Randox Laboratories Ltd
• 12.10. Wondfo
• Similar data will be provided for each market player.

Emerging Market Players

• 12.11. HORIBA, Ltd*
  • 12.11.1. Pipeline Products Description
  • 12.11.2. Product Key Performance Indicators (KPIs)
  • 12.11.3. Key Activities
  • 12.11.4. Market Entry Timelines
  • 12.11.5. Product Penetration Rate
  • 12.11.6. Sales Estimation and Projections
• 12.12. Arkray, Inc.
• 12.13. URIT Medical Electronic Co., Ltd.
• 12.14. DIRUI Industrial Co., Ltd.
• 12.15. Medica Corporation
• 12.16. EKF Diagnostics
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1 About Us and Services
• 12.2 Contact Us